References
- American Society for Reproductive Medicine (ASRM). Recurrent pregnancy loss. Patient fact sheet. 2008. Available from: http://www.asrm.org/Guidelines/
- Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod 1994;50:461–6
- Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601–11
- Weimar CH, Kavelaars A, Brosens JJ, et al. Endometrial stromal cells of women with recurrent miscarriage fail to discriminate between high- and low-quality human embryos. PLoS One 2012;7:e41424
- Li TC, Makris M, Tomsu M, et al. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002;8:463–81
- Sanchez JM, Franzi L, Collia F, et al. Cytogenetic study of spontaneous abortions by transabdominal villus sampling and direct analysis of villi. Prenat Diagn 1999;19:601–3
- Tunc E, Demirhan O, Demir C, Tastemir D. Cytogenetic study of recurrent miscarriages and their parents. Genetika 2007;43:545–52
- Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996;66:24–9
- Smith ML, Schust DJ. Endocrinology and recurrent early pregnancy loss. Semin Reprod Med 2011;29:482–90
- Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med 2006;24:33–9
- Hadinedoushan H, Mirahmadian M, Aflatounian A. Increased natural killer cell cytotoxicity and IL-2 production in recurrent spontaneous abortion. Am J Reprod Immunol 2007;58:409–14
- Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clin Chim Acta 2011;412:702–8
- Daher S, de Arruda Geraldes Denardi K, Blotta MH, et al. Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004;62:151–7
- Dudley DJ. Recurrent pregnancy loss and cytokines. Not as simple as it seems. JAMA 1995;273:1958–9
- Nielsen HS, Witvliet MD, Steffensen R, et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 2010;87:67–73
- Gardella JR, Hill JA III. Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 2000;18:407–24
- Christiansen OB. A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996;2:271–93
- Wang N, Geng L, Zhang S, et al. Expression of PRB, FKBP52 and HB-EGF relating with ultrasonic evaluation of endometrial receptivity. PLoS One 2012;7:e34010
- Tranguch S, Smith DF, Dey SK. Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation. Reprod Biomed Online 2006;13:651–60
- Tranguch S, Cheung-Flynn J, Daikoku T, et al. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 2005;102:14326–31
- Silverstein AM, Galigniana MD, Kanelakis KC, et al. Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein. J Biol Chem 1999;274:36980–6
- Barent RL, Nair SC, Carr DC, et al. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol 1998;12:342–54
- Cheung-Flynn J, Prapapanich V, Cox MB, et al. Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 2005;19:1654–66
- Davies TH, Sanchez ER. Fkbp52. Int J Biochem Cell Biol 2005;37:42–7
- Ratajczak T, Ward BK, Cluning C, Allan RK. Cyclophilin 40: an Hsp90-cochaperone associated with apo-steroid receptors. Int J Biochem Cell Biol 2009;41:1652–5
- Ratajczak T, Ward BK, Minchin RF. Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem 2003;3:1348–57
- Tranguch S, Wang H, Daikoku T, et al. FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J Clin Invest 2007;117:1824–34
- Storer CL, Dickey CA, Galigniana MD, et al. FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab 2011;22:481–90
- Conneely OM, Mulac-Jericevic B, Lydon JP. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003;68:771–8